Financial Highlights | Lee's Pharmaceutical

Financial Highlights

For the year ended 31 December
HK$'000
2024
2023
Change
Revenue
1,399,969
1,053,034
+32.9%
Gross Profit
753,355
551,311
+36.6%
Gross Profit Margin (%)
53.8%
52.4%
+1.4pp
EBITDA
248,277
179,680
+38.2%
Profit from Operations
113,142
43,553
+159.8%
Profit attributable to shareholders of the Company
93,099
16,698
+457.5%
Equity attributable to the owners of the Company
1,651,799
2,038,955
-19.0%
Basic EPS
HK 15.81 cents
HK 2.84 cents
+456.7%
Diluted EPS
HK 15.81 cents
HK 2.84 cents
+456.7%
Total Dividend per Share (Interim + Final)
HK 4.5 cents
HK 1.80 cents
+150.0%